2m 2m 2m 2m 2m 2m 2m
TANDEM DIABETES (TNDM)
NASDAQ
$18.76-$0.02 (-0.08%)
Price as of Nov 12, 2026 9:10 AM EST- $1.3BMarket Cap
- 3.93%1-Year Change
- Medical DevicesIndustry
TANDEM DIABETES (TNDM)
$18.76-$0.02 (-0.08%)
TNDM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.77 | ||
Change | +$0.06 (+0.32%) | ||
Open | $18.65 | ||
High | $19.76 | ||
Low | $18.46 | ||
Previous Close | $18.71 | ||
Volume | 2,553,861 | ||
30-Day Average Volume | 2,603,326 | ||
1-Week Change | -1.47% | ||
1-Month Change | 16.51% | ||
1-Year Change | 3.93% | ||
3-Year Change | 31.44% | ||
5-Year Change | -86.00% | ||
Fundamentals | |||
Shares Outstanding | 69.8M | ||
Total Assets | $1.2B | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $283.7M | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$5.7M | ||
EBITDA | -$1.2M | ||
Net Working Capital | $564.6M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -1,557 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 10 | ||
P/E | -188 | ||
PEG | -3 | ||
Price/Free Cash Flow | -238 | ||
Price/Operating Cash Flow | -1,600 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 10/10/2017 | ||
Earnings & Revenue